Near-patient  ||| S:0 E:13 ||| JJ
testing  ||| S:13 E:21 ||| NN
devices  ||| S:21 E:29 ||| NNS
to  ||| S:29 E:32 ||| TO
monitor  ||| S:32 E:40 ||| VB
vitamin  ||| S:40 E:48 ||| JJ
K  ||| S:48 E:50 ||| NNP
antagonists  ||| S:50 E:62 ||| JJ
Monitoring  ||| S:62 E:73 ||| NN
of  ||| S:73 E:76 ||| IN
the  ||| S:76 E:80 ||| DT
anticoagulant  ||| S:80 E:94 ||| JJ
effect  ||| S:94 E:101 ||| NN
with  ||| S:101 E:106 ||| IN
the  ||| S:106 E:110 ||| DT
International  ||| S:110 E:124 ||| NNP
normalized  ||| S:124 E:135 ||| JJ
ratio  ||| S:135 E:141 ||| NN
( ||| S:141 E:142 ||| -LRB-
INR ||| S:142 E:145 ||| NNP
)  ||| S:145 E:147 ||| -RRB-
is  ||| S:147 E:150 ||| VBZ
essential  ||| S:150 E:160 ||| JJ
for  ||| S:160 E:164 ||| IN
patients  ||| S:164 E:173 ||| NNS
receiving  ||| S:173 E:183 ||| VBG
vitamin  ||| S:183 E:191 ||| JJ
K  ||| S:191 E:193 ||| NN
antagonists  ||| S:193 E:205 ||| NNS
( ||| S:205 E:206 ||| -LRB-
VKAs ||| S:206 E:210 ||| NNP
) ||| S:210 E:211 ||| -RRB-
.  ||| S:211 E:213 ||| .
The  ||| S:213 E:217 ||| DT
majority  ||| S:217 E:226 ||| NN
of  ||| S:226 E:229 ||| IN
point  ||| S:229 E:235 ||| NN
of  ||| S:235 E:238 ||| IN
care  ||| S:238 E:243 ||| NN
( ||| S:243 E:244 ||| -LRB-
POC ||| S:244 E:247 ||| NNP
)  ||| S:247 E:249 ||| -RRB-
devices  ||| S:249 E:257 ||| NNS
for  ||| S:257 E:261 ||| IN
INR  ||| S:261 E:265 ||| NNP
monitoring  ||| S:265 E:276 ||| NN
has  ||| S:276 E:280 ||| VBZ
shown  ||| S:280 E:286 ||| VBN
a  ||| S:286 E:288 ||| DT
good  ||| S:288 E:293 ||| JJ
precision  ||| S:293 E:303 ||| NN
and  ||| S:303 E:307 ||| CC
accuracy  ||| S:307 E:316 ||| NN
with  ||| S:316 E:321 ||| IN
results  ||| S:321 E:329 ||| NNS
similar  ||| S:329 E:337 ||| JJ
to  ||| S:337 E:340 ||| TO
those  ||| S:340 E:346 ||| DT
obtained  ||| S:346 E:355 ||| VBN
in  ||| S:355 E:358 ||| IN
a  ||| S:358 E:360 ||| DT
laboratory ||| S:360 E:370 ||| NN
.  ||| S:370 E:372 ||| .
In  ||| S:372 E:375 ||| IN
many  ||| S:375 E:380 ||| JJ
countries ||| S:380 E:389 ||| NNS
,  ||| S:389 E:391 ||| ,
INR  ||| S:391 E:395 ||| NNP
POC  ||| S:395 E:399 ||| NNP
devices  ||| S:399 E:407 ||| NNS
are  ||| S:407 E:411 ||| VBP
widely  ||| S:411 E:418 ||| RB
used  ||| S:418 E:423 ||| VBN
at  ||| S:423 E:426 ||| IN
home  ||| S:426 E:431 ||| NN
by  ||| S:431 E:434 ||| IN
the  ||| S:434 E:438 ||| DT
patients  ||| S:438 E:447 ||| NNS
for  ||| S:447 E:451 ||| IN
self-testing ||| S:451 E:463 ||| JJ
.  ||| S:463 E:465 ||| .
Their  ||| S:465 E:471 ||| PRP$
use  ||| S:471 E:475 ||| NN
in  ||| S:475 E:478 ||| IN
the  ||| S:478 E:482 ||| DT
hospital  ||| S:482 E:491 ||| NN
by  ||| S:491 E:494 ||| IN
the  ||| S:494 E:498 ||| DT
clinical  ||| S:498 E:507 ||| JJ
staff  ||| S:507 E:513 ||| NN
( ||| S:513 E:514 ||| -LRB-
doctor  ||| S:514 E:521 ||| NN
or  ||| S:521 E:524 ||| CC
nurses ||| S:524 E:530 ||| NNS
)  ||| S:530 E:532 ||| -RRB-
for  ||| S:532 E:536 ||| IN
bedside  ||| S:536 E:544 ||| JJ
measurement  ||| S:544 E:556 ||| NN
is  ||| S:556 E:559 ||| VBZ
also  ||| S:559 E:564 ||| RB
growing ||| S:564 E:571 ||| VBG
.  ||| S:571 E:573 ||| .
The  ||| S:573 E:577 ||| DT
INR  ||| S:577 E:581 ||| NNP
POC  ||| S:581 E:585 ||| NNP
testing  ||| S:585 E:593 ||| NN
is  ||| S:593 E:596 ||| VBZ
performed  ||| S:596 E:606 ||| VBN
using  ||| S:606 E:612 ||| VBG
fully  ||| S:612 E:618 ||| RB
automated  ||| S:618 E:628 ||| JJ
devices ||| S:628 E:635 ||| NNS
.  ||| S:635 E:637 ||| .
Capillary  ||| S:637 E:647 ||| JJ
blood  ||| S:647 E:653 ||| NN
samples  ||| S:653 E:661 ||| NNS
are  ||| S:661 E:665 ||| VBP
easy  ||| S:665 E:670 ||| JJ
to  ||| S:670 E:673 ||| TO
obtain ||| S:673 E:679 ||| VB
.  ||| S:679 E:681 ||| .
In  ||| S:681 E:684 ||| IN
the  ||| S:684 E:688 ||| DT
emergency  ||| S:688 E:698 ||| NN
room ||| S:698 E:702 ||| NN
,  ||| S:702 E:704 ||| ,
POC  ||| S:704 E:708 ||| NNP
INR  ||| S:708 E:712 ||| NNP
devices  ||| S:712 E:720 ||| NNS
are  ||| S:720 E:724 ||| VBP
commonly  ||| S:724 E:733 ||| RB
used ||| S:733 E:737 ||| VBN
.  ||| S:737 E:739 ||| .
This  ||| S:739 E:744 ||| DT
improves  ||| S:744 E:753 ||| VBZ
the  ||| S:753 E:757 ||| DT
quality  ||| S:757 E:765 ||| NN
of  ||| S:765 E:768 ||| IN
care  ||| S:768 E:773 ||| NN
for  ||| S:773 E:777 ||| IN
patient  ||| S:777 E:785 ||| NN
with  ||| S:785 E:790 ||| IN
suspicion  ||| S:790 E:800 ||| NN
of  ||| S:800 E:803 ||| IN
VKAs  ||| S:803 E:808 ||| JJ
overdosage ||| S:808 E:818 ||| NN
.  ||| S:818 E:820 ||| .
INR  ||| S:820 E:824 ||| NNP
measurement  ||| S:824 E:836 ||| NN
using  ||| S:836 E:842 ||| VBG
bedside  ||| S:842 E:850 ||| JJ
monitors  ||| S:850 E:859 ||| NNS
is  ||| S:859 E:862 ||| VBZ
also  ||| S:862 E:867 ||| RB
of  ||| S:867 E:870 ||| IN
great  ||| S:870 E:876 ||| JJ
interest  ||| S:876 E:885 ||| NN
in  ||| S:885 E:888 ||| IN
care  ||| S:888 E:893 ||| NN
units  ||| S:893 E:899 ||| NNS
for  ||| S:899 E:903 ||| IN
specific  ||| S:903 E:912 ||| JJ
populations  ||| S:912 E:924 ||| NNS
of  ||| S:924 E:927 ||| IN
patients  ||| S:927 E:936 ||| NNS
like  ||| S:936 E:941 ||| IN
paediatrics  ||| S:941 E:953 ||| NN
or  ||| S:953 E:956 ||| CC
geriatrics ||| S:956 E:966 ||| NN
.  ||| S:966 E:968 ||| .
Moreover ||| S:968 E:976 ||| RB
,  ||| S:976 E:978 ||| ,
bedside  ||| S:978 E:986 ||| VBG
INR  ||| S:986 E:990 ||| NNP
monitoring  ||| S:990 E:1001 ||| NN
may  ||| S:1001 E:1005 ||| MD
be  ||| S:1005 E:1008 ||| VB
useful  ||| S:1008 E:1015 ||| JJ
in  ||| S:1015 E:1018 ||| IN
anticoagulant  ||| S:1018 E:1032 ||| JJ
clinics  ||| S:1032 E:1040 ||| NNS
or  ||| S:1040 E:1043 ||| CC
when  ||| S:1043 E:1048 ||| WRB
the  ||| S:1048 E:1052 ||| DT
care  ||| S:1052 E:1057 ||| NN
unit  ||| S:1057 E:1062 ||| NN
is  ||| S:1062 E:1065 ||| VBZ
far  ||| S:1065 E:1069 ||| RB
from  ||| S:1069 E:1074 ||| IN
a  ||| S:1074 E:1076 ||| DT
laboratory ||| S:1076 E:1086 ||| NN
.  ||| S:1086 E:1088 ||| .
Although  ||| S:1088 E:1097 ||| IN
the  ||| S:1097 E:1101 ||| DT
bedside  ||| S:1101 E:1109 ||| JJ
INR  ||| S:1109 E:1113 ||| NN
monitors  ||| S:1113 E:1122 ||| NNS
are  ||| S:1122 E:1126 ||| VBP
easy  ||| S:1126 E:1131 ||| JJ
to  ||| S:1131 E:1134 ||| TO
use ||| S:1134 E:1137 ||| VB
,  ||| S:1137 E:1139 ||| ,
their  ||| S:1139 E:1145 ||| PRP$
implementation  ||| S:1145 E:1160 ||| NN
requires  ||| S:1160 E:1169 ||| VBZ
adequate  ||| S:1169 E:1178 ||| JJ
training  ||| S:1178 E:1187 ||| NN
and  ||| S:1187 E:1191 ||| CC
intermittent  ||| S:1191 E:1204 ||| JJ
re-evaluation  ||| S:1204 E:1218 ||| NN
of  ||| S:1218 E:1221 ||| IN
any  ||| S:1221 E:1225 ||| DT
person  ||| S:1225 E:1232 ||| NN
performing  ||| S:1232 E:1243 ||| VBG
the  ||| S:1243 E:1247 ||| DT
tests  ||| S:1247 E:1253 ||| NNS
to  ||| S:1253 E:1256 ||| TO
ensure  ||| S:1256 E:1263 ||| VB
reliability  ||| S:1263 E:1275 ||| VBN
of  ||| S:1275 E:1278 ||| IN
results ||| S:1278 E:1285 ||| NNS
.  ||| S:1285 E:1287 ||| .
Such  ||| S:1287 E:1292 ||| JJ
equipment  ||| S:1292 E:1302 ||| NN
must  ||| S:1302 E:1307 ||| MD
comply  ||| S:1307 E:1314 ||| VB
with  ||| S:1314 E:1319 ||| IN
EN  ||| S:1319 E:1322 ||| NNP
ISO  ||| S:1322 E:1326 ||| NNP
22870  ||| S:1326 E:1332 ||| CD
standard  ||| S:1332 E:1341 ||| NN
for  ||| S:1341 E:1345 ||| IN
POC  ||| S:1345 E:1349 ||| NNP
testing  ||| S:1349 E:1357 ||| NN
accreditation ||| S:1357 E:1370 ||| NN
,  ||| S:1370 E:1372 ||| ,
under  ||| S:1372 E:1378 ||| IN
the  ||| S:1378 E:1382 ||| DT
supervision  ||| S:1382 E:1394 ||| NN
of  ||| S:1394 E:1397 ||| IN
a  ||| S:1397 E:1399 ||| DT
biologist ||| S:1399 E:1408 ||| NN
.  ||| S:1408 E:1410 ||| .
In  ||| S:1410 E:1413 ||| IN
order  ||| S:1413 E:1419 ||| NN
to  ||| S:1419 E:1422 ||| TO
achieve  ||| S:1422 E:1430 ||| VB
these  ||| S:1430 E:1436 ||| DT
targets ||| S:1436 E:1443 ||| NNS
,  ||| S:1443 E:1445 ||| ,
connect  ||| S:1445 E:1453 ||| VBP
the  ||| S:1453 E:1457 ||| DT
instrument  ||| S:1457 E:1468 ||| NN
to  ||| S:1468 E:1471 ||| TO
the  ||| S:1471 E:1475 ||| DT
laboratory ||| S:1475 E:1485 ||| NN
's  ||| S:1485 E:1488 ||| POS
data  ||| S:1488 E:1493 ||| NN
management  ||| S:1493 E:1504 ||| NN
system  ||| S:1504 E:1511 ||| NN
is  ||| S:1511 E:1514 ||| VBZ
essential ||| S:1514 E:1523 ||| JJ
.  ||| S:1523 E:1525 ||| .
